Back to School: How biopharma can reboot drug development. Access exclusive analysis here

NTMD proposes follow-on, releases A-HeFT data

NitroMed (NTMD) proposed to raise $65.2 million in a follow-on underwritten by JP Morgan; Pacific Growth; Deutsche Bank; and

Read the full 195 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE